INFINIITYDEFI 交易所

Our company is composed of an award-winning team in whole exome sequencing of neurodevelopmental diseases, one of the top research teams in psychiatric research and psychiatric disease assessment, and a local leading team in autism assessment and intervention.
本公司由研究神經發育疾病全外顯子測序的獲獎團隊、精神病學研究和評估的頂級研究團隊,和一個自閉症評估和行為介入的專家小組組成。

image
image

GENREWARDS EXCHANGE

To provide more affordable, efficient, personal, and remote intervention as early as possible to children afflicted with ASD, so as to significantly improve their quality of life.

為兒童提供自閉症的初步篩查和早期診斷,並為患自閉症兒童儘早提供負擔得起的、有效的、個人化的和遠程的行為療育訓練,以改善他們的生活質素。

 

TED FINANCE LOGIN

To become a leading innovative health care R&D company in Hong Kong and the greater China area.

成為香港和大中華地區領先的創新醫療保健研發公司。

image
image

HELPSEED LOGIN

To become a leading innovative health care R&D company in Hong Kong and the greater China area.

成為香港和大中華地區領先的創新醫療保健研發公司。

Our Services 我們的服務 

We are the first company to combine genetic and behavioral screening for ASD and personalized intervention in Hong Kong. Our patented technology for the screening and subtyping of ASD enable the predict of high-risk ASD children with higher accuracy, so that intervention training could offer to them as early as possible.

我們是香港首家將基因和行為篩查結合用於自閉症檢測和個人化療育的公司。我們的專利技術可以更準確地爲兒童預測患有自閉症的風險,因此可以儘早進行療育介入。

image
image

MULTIBIT 交易所

Genetic Screening 基因檢測

The underlying aetiologies are diversified, ranging from genetic conditions to environmental conditions. The 80% heritability rate of ASD suggested the necessity of genetic testing for ASD screening (Kristiina Tammimies et al., 2015). With the advance of sequencing technology, massively parallel detection of variants is now possible, enable more accurate and earlier screening and identify recurrence risk in families.

自閉症可能是由多種複雜因素引起的,包括遺傳惡化、微生物和環境因素。自閉症80%的遺傳率表明基因檢測的重要性。測序技術的進步使我們可以更準確、更早地評估自閉症的風險和判斷家族復發的可能性。

Eye-tracking screening 眼動追踪檢測 

Some early signs of ASD can be detected at 6 months of age. People with ASD usually show reliable and constant gaze abnormalities, which helps in risk assessment (Thomas Frazier et al., 2017).

一些自閉症的早期跡象,可以在嬰兒6個月時檢測到。自閉症患者通常表現出一種凝視異常模式,有助臨床上的風險評估。

All-in-one system for ASD 多合一自閉症系統 

Early diagnosis and intervention are crucial and helpful to give children the best chance of developing to their full potential (Lori-Ann R Sacrey et al., 2015). Our company has developed an all-in-one system for parents of children suspected/afflicted with ASD to perform initial screening, follow up genetic testing, and intervention after screening.

研究表明,早期診斷和介入是至關重要的,有助於讓孩子們有最好的機會充分發展他們的潛能。本公司研發了一個為懷疑/患自閉症的孩子的父母提供的多合一自閉症系統,可以進行初步篩查,跟踪基因檢測以及篩查後進行介入和培訓。

Reference:
1. Sacrey, L., Bennett, J., & Zwaigenbaum, L. (2015). Early Infant Development and Intervention for Autism Spectrum Disorder. Journal Of Child Neurology, 30(14), 1921-1929.
2. Frazier, T., Strauss, M., Klingemier, E., Zetzer, E., Hardan, A., Eng, C., & Youngstrom, E. (2017). A Meta-Analysis of Gaze Differences to Social and Nonsocial Information Between Individuals With and Without Autism. Journal Of The American Academy Of Child & Adolescent Psychiatry, 56(7), 546-555.
3. Tammimies, K., Marshall, C., Walker, S., Kaur, G., Thiruvahindrapuram, B., & Lionel, A. et al. (2015). Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder. JAMA, 314(9), 895.
image
image

BEE CRYPTO VALUE

Our patented technology for screening and subtyping of ASD enables accurate prediction of ASD risk in children, so that intervention training could offer to them as early as possible.

我們的專利技術可以更準確地爲兒童預測患有自閉症的風險,因此可以儘早進行療育介入。

LEOX EXCHANGE

Autism is a neurodevelopmental disorder that usually occurs before the age of 3. About 1 in 54 children has been identified with autism spectrum disorder (ASD) according to estimates from CDC’s Autism and Developmental Disabilities Monitoring Network (Centers for Disease Control and Prevention, 2020). The estimated number of ASD cases was 14,000,000 in China (The Chinese University of Hong Kong, 2013). In Hong Kong, there are an estimated 75,000 – 113,000 people with ASD (Autism Hong Kong, 2019).

自閉症是一種神經性發展遲緩,通常出現在3歲以前。根據美國疾控中心 2016 年的統計數據,每54名兒童中就有1名患有自閉症 (美國疾病管制與預防中心, 2020)。中國的自閉症案例估計達14,000,000 宗 (香港中文大學, 2013)。在香港,估計共有75,000 – 113,000 名自閉症患者(香港自閉症聯盟, 2019)。

ETHORSE EXCHANGE

BNGT APP

徐國榮教授 Prof. Stephen Kwok Wing TSUI  

香港中文大學生物醫學學院教授及副院長(研究)Professor and Associate director (research) in the School of Biomedical Sciences
香港中文大學基因組學及生物信息學課程主任 Director of the Hong Kong Bioinformatics Centre and the Centre for Microbial Genomics and Proteomics

徐教授現任生物醫學學院教授及副院長(研究),香港中文大學基因組學及生物信息學課程主任,微生物基因組和蛋白質組中心主任,香港生物信息中心主任,血管醫學研究所成員,香港生物化學及分子生物學會會員等。徐教授於1995年在香港中文大學(CUHK)獲得生物化學博士學位,其後於1997年被委任為香港中文大學生物化學系助理教授,並於2004年晉升為教授。 他也是HapMap國際協會的前會員,從事人類染色體3P的單核苷酸多態性的研究工作。他的主要研究是新一代基因測序,生物信息學,人類遺傳疾病和分子微生物學。
TSUI Kwok-Wing Stephen is currently a professor and vice director (research) in the School of Biomedical Sciences, directors of the Hong Kong Bioinformatics Centre and the Centre for Microbial Genomics and Proteomics, and associate director of the CUHK-BGI Innovation Institute of Trans-omics in the Chinese University of Hong Kong (CUHK). In 1995, he received his Doctor of Philosophy (PhD) degree in Biochemistry at CUHK and his PhD thesis is related to the decoding of the human genome. He was then appointed as an Assistant Professor in the Biochemistry Department in 1997 and promoted to the full professorship in 2004. He was a former member of the International HapMap Consortium working on the single nucleotide polymorphisms of human chromosome 3p. He is very interested in bioinformatics, comparative genomics and molecular biology of clinical pathogens.

蘇漢昌醫生 Prof. Hon Cheong SO  

香港中文大學生物醫學學院助理教授 Assistant Professor in the School of Biomedical Sciences
內外全科醫學士, 哲學博士 MBBS, PhD

蘇漢昌教授於2012年獲得香港大學的內外全科醫學士學位並博士學位。他的博士研究專注於統計和精神病學基因組學。他獲得了無數獎項,包括裘槎基金會獎學金和香港大學醫學院最佳博士學位論文的金獎。他曾在瑪麗醫院和青山醫院擔任住院醫師。他於2016年1月加入香港中文大學生物醫學學院擔任助理教授,亦是香港中文大學精神病學系助理教授(禮任教授)。他的主要研究包括開發和應用新穎的統計和計算方法論到不同組學和臨床數據。
Prof. SO Hon Cheong received his Bachelor of Medicine and Bachelor of Surgery (MBBS) degree together with a PhD degree in 2012 from The University of Hong Kong (HKU). His PhD research focused on statistical and psychiatric genomics. He has received numerous awards for his academic achievement, including the Croucher Foundation Scholarship and the Dr. Stephen K.P. Chang Gold Medal for the best PhD thesis in the Faculty of Medicine, HKU. Prior to taking up the current academic post, he worked as a resident psychiatrist in Queen Mary Hospital and Castle Peak Hospital. He joined the School of Biomedical Sciences of The Chinese University of Hong Kong as an Assistant Professor in Jan 2016 and is also currently assistant professor (by courtesy) of the Department of Psychiatry, CUHK. His main research interests include the development and application of novel statistical and computational methodologies to “omics” and clinical data in general.

曾君蘭教授 Prof. Vicky Kwan Lan TSANG  

香港註冊職業治療師 Registered Occupational Therapist, Hong Kong Occupational Therapists Board
美國註冊職業治療師 Occupational Therapist Registered, AOTA Certification Board, USA

曾教授現任東華學院副教授 (職業治療學)。她先後於香港理工學院及美國紐約大學完成職業治療專業文憑及職業治療進階碩士主修發展障礙。其後,她在澳洲迪肯大學獲得博士學位。她是香港和美國的註冊職業治療師,並完成修讀國際認可的感覺統合動作計劃測驗 (SIPT)、兒科神經發展治療 (NDT),及匈牙利彼圖學院頒發之引導式教育的證書課程。曾博士已往在美國和香港執業,擁有至少15年臨床工作經驗;亦在高等教育方面擔當專任教授逾15年。
Dr. Vicky Tsang is currently an associate professor (occupational therapy) in Tung Wah College. She first graduated from Hong Kong Polytechnic with a professional diploma in Occupational Therapy. Then she completed Advanced MA degree in Occupational Therapy with specialization in Developmental Disabilities in New York University, USA. She received her PhD in Deakin University, Australia. She is a registered occupational therapist, both in Hong Kong and USA. She completed the internationally recognized certification courses in Sensory Integration and Praxis Test (SIPT), Neuro-developmental therapy (NDT) in Pediatrics, and, Conductive Education conferred by Pető Institute of Hungary. Dr. Tsang has had extensive work experience as a clinical practitioner in Hong Kong and USA for at least 15 years, and, as an academic professional in higher education for more than 15 years.

SHIBARIUM DAO LOGIN

Our screening tools include genome-wide association tests (GWAS), whole exome analysis, developmental assessments, and automated assessment system.
我們的篩查方法包括全基因組關聯測試(GWAS),全外顯子組分析(WES) ,發展評估和自動化評估系統。 

APBC APP

We offer different plans for ASD screening. Please contact us for more details.
我們提供不同的自閉症篩查計劃。請與我們聯繫了解更多詳情。

 

TOKEN CHEETAH 交易所

Unit 502, 5/F, Biotech Centre 1, 9 Science Park West Avenue, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong.
香港科學園科技大道西9號生物科技中心一座5樓502室 
(+852) 3590 8435
(+852) 6518 4701
  • image
  • image
  • image

COPYRIGHT © 2021 WELLMIND BIOMED TECHNOLOGY HOLDINGS LIMITED.